Rivastigmine-L-tartrate ≥95%, crystalline solid

Proveedor: Cayman Chemical
Peligro

Sinónimos: Rivastigmine tartrate, (S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate (2R,3R)-2,3-dihydroxysuccinate, N-Ethyl-N-methylcarbamic Acid 3-[(S)-1-(Dimethylamino)ethyl]phenyl Ester L-Tartrate, 3-[(S)-1-(Dimethylamino)ethyl]phenyl N-Ethyl-N-methylcarbamate L-Tartrate

14270-100 14270-250 14270-1 14270-500
CAYM14270-100EA 172 EUR
CAYM14270-100 CAYM14270-250 CAYM14270-1 CAYM14270-500
Rivastigmine-L-tartrate ≥95%, crystalline solid
Rivastigmine-L-tartrate

Rivastigmine is an irreversible inhibitor of acetylcholinesterase (IC50=4,15 µm) and butyrylcholinesterase (IC50=37 nM).


It acts by covalently modifying a serine residue in the active site by carbamoylation. Rivastigmine has found use in modifying the course of neurodegenerative diseases, including Parkinson’s disease and Alzheimer’s disease, as it stabilises or reduces the rate of decline in certain cognitive functions.

Formula: C₁₄H₂₂N₂O₂·C₄H₆O₆
MW: 400,43 g/mol
Temperatura de almacenaje: Congelador
Número MDL: MFCD03700731
Núm. CAS: 129101-54-8

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Más About VWR